Please assess the completion status of the following clinical trial:

Trial Title: Treatment Utility of Postpartum Antibiotics in Chorioamnionitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of chorioamnionitis~* Undergoing cesarean section for delivery~Exclusion Criteria:~* Multiple gestations,~* Allergy to beta-lactam antibiotics~* Patients with estimated creatinine clearance (ClCr) less than 70 mL/min~* Maternal fever explained by etiology other than chorioamnionitis~* Inability to comply with the study protocol.

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Postpartum Antibiotics (Type: EXPERIMENTAL): Patients will receive one additional dose of postpartum antibiotics (Clinda, Gentamicin)
- No postpartum antibiotics (Type: PLACEBO_COMPARATOR): No further postpartum antibiotics

Based on this trial design, predict the completion outcome and termination type (if applicable).